Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Non Operating Income (2021 - 2026)

HeartSciences' Non Operating Income history spans 6 years, with the latest figure at -$56268.0 for Q1 2026.

  • For Q1 2026, Non Operating Income rose 65.86% year-over-year to -$56268.0; the TTM value through Jan 2026 reached -$688440.0, down 235.66%, while the annual FY2025 figure was -$412658.0, 37.81% down from the prior year.
  • Non Operating Income reached -$56268.0 in Q1 2026 per HSCS's latest filing, up from -$277366.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $33626.0 in Q2 2024 to a low of -$277366.0 in Q4 2025.
  • Average Non Operating Income over 5 years is -$98910.2, with a median of -$97885.0 recorded in 2024.
  • Peak YoY movement for Non Operating Income: surged 199.77% in 2024, then tumbled 854.34% in 2025.
  • A 5-year view of Non Operating Income shows it stood at -$31606.0 in 2022, then tumbled by 464.56% to -$178435.0 in 2023, then soared by 45.14% to -$97885.0 in 2024, then crashed by 183.36% to -$277366.0 in 2025, then surged by 79.71% to -$56268.0 in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Non Operating Income are -$56268.0 (Q1 2026), -$277366.0 (Q4 2025), and -$180875.0 (Q3 2025).